Stockwinners Market Radar for August 02, 2017 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

18:57 EDT XPO Logistics backs FY17 adjusted EBITDA view of at least $1.365B

18:17 EDT Tesla says expects 'significantly better' operating cash flow in 2H17 - Says not considering an equity raise.

18:10 EDT Tesla CEO Musk says 'This is the best I've ever felt about the company'

18:02 EDT Tesla says expects to keep majority of production in U.S. - Says does anticipate building factories in China and Europe.

17:53 EDT Cable ONE raises quarterly dividend 25c to $1.75 per share - The board of directors of Cable One declared a quarterly cash dividend of $1.75 per share, an increase of 25c per share in the company's quarterly cash dividend. The dividend is payable on September 1, 2017, to stockholders of record at the close of business on August 15, 2017.

17:46 EDT Tesla says on track to produce 5,000 units per week by end of year - Says targeting 10,000 unit production week by end of next year. Comments from Q2 earnings conference call.

17:42 EDT Antero Resources reports 14% increase in estimated mid-year 3P reserves - Antero's estimated proved reserves at June 30, 2017 were 16.5 Tcfe, a 7% increase compared to estimated proved reserves at December 31, 2016. Proved, probable and possible. or 3P, reserves at mid-year 2017 totaled 53.0 Tcfe, which represents a 14% increase compared to year-end 2016. Proved and probable reserves comprise over 96% of the total 3P reserves. Drill bit only finding and development cost, including revisions, was 47c per Mcfe for 1H17. All-in finding and development cost for estimated proved reserve additions was 48c per Mcfe for mid-year 2017. Pre-tax PV-10 of proved reserves at mid-year 2017 was $10.1B at 6/30/2017 strip pricing, including hedges.

17:40 EDT Lockheed Martin awarded $161.4M government contract - Lockheed Martin Missile and Fire Control, Dallas, Texas, was awarded a $161,433,900 firm-fixed-price contract for the production of 150 Army Tactical Missile Guided Missile and Launching Assemblies' Service Life Extension Program. One bid was solicited and one bid was received. Work will be performed in Dallas, Texas; Lufkin, Texas; Camden, Arkansas; Vergennes, Vermont; Boulder, Colorado; Middletown, Connecticut; Clearwater, Florida; St. Louis, Missouri; Joplin, Missouri; Chambersburg, Pennsylvania; and Cincinnati, Ohio, with an estimated completion date of Feb. 3, 2020. Fiscal 2017 Army procurement appropriations funds in the amount of $161,433,900 were obligated at the time of the award. U.S. Army Contracting Command, Redstone Arsenal, Alabama, is the contracting activity.

17:34 EDT Callon Petroleum sees FY17 production 22,500-25,5000 BOE/d - Sees FY17 production 78% oil. Sees FY17 CapEx $350M.

17:31 EDT Exelixis backs FY17 operating expenses view $290M-$310M

17:24 EDT Concho Resources raises FY17 production growth view to 24%-26% from 21%-25% - For full-year 2017, Concho raised its production growth guidance to a range of 24% to 26% and expects oil production to grow by more than 25%. The Company expects capital expenditures, excluding acquisitions, will approximate the midpoint of the guidance range of $1.6 billion to $1.8 billion. Additionally, for the second half of 2017, the Company expects oil and natural gas production expense will be at the high end of the guidance range of $5.50 per Boe to $6.00 per Boe, with production expense tracking the midpoint of the range for full-year 2017. The Company lowered full-year 2017 guidance for depletion, depreciation and amortization expense to a range of $16 per Boe to $18 per Boe, as compared to previous guidance of $17 per Boe to $19 per Boe.

17:22 EDT Spectra Energy Partners increases quarterly cash distribution - Spectra Energy Partners announced that the board of the general partner of its general partner declared a quarterly cash distribution to unitholders of 71.375c per unit, an increase of 1.25c over the previous level of 70.125c per unit. The cash distribution is payable on August 29 to unitholders of record at the close of business on August 15. This quarterly cash distribution equates to $2.855 per unit on an annual basis.

17:21 EDT Spectra Energy Partners raises quarterly distribution to 71.375c per unit - The cash distribution is payable on August 29 to unitholders of record at the close of business on August 15.

17:15 EDT Straight Path stockholders approve merger with Verizon - Straight Path Communications Inc. (STRP) stockholders today voted to adopt the merger agreement between Straight Path Communications Inc., Verizon Communications Inc. (VZ) and Waves Merger Sub I, Inc., with 89% of the votes entitled to be cast at the special meeting of stockholders voting; and of the votes cast, approximately 99% were cast in favor of the proposal.

17:13 EDT International Flavors raises quarterly dividend 8% to 69c per share - IFF authorized a quarterly dividend of 69c per share of the company's common stock, an increase of 5c, or 8%, from the current quarterly dividend of 64c per share. The quarterly dividend will be payable on October 6, 2017 to shareholders of record as of September 25, 2017.

17:10 EDT Macquarie Infrastructure forms JV with Intersect Power - Macquarie Infrastructure has formed a joint venture with Intersect Power, a developer of renewable power generation and storage projects across the U.S. MIC has committed to supporting the entity with up to $135.0 million of equity, contingent equity and credit facilities to fund Intersect Power's pipeline of development and expansion.

17:10 EDT Eclipse Resources sees FY17 production 315-320 MMcfe/d

17:09 EDT SAExploration to reschedule Q2 earnings and conference call - SAExploration Holdings announced plans to reschedule the release of its unaudited consolidated financial results for the second quarter and first six months ended June 30, 2017. Concurrently, SAE will reschedule its conference call previously scheduled for Thursday, August 3, 2017 at 10:00 a.m. ET to discuss these results and other related matters. The company now expects to release its unaudited consolidated financial results for the second quarter and first six months ended June 30, 2017 on or before August 21, 2017. SAE will disseminate additional information regarding the new date and time of the conference call to discuss these results and other related matters at a later date.

17:08 EDT Eclipse Resources sees Q3 production 350-355 MMcfe/d

17:04 EDT MarineMax announces stock repurchase program - MarineMax announced that its board of directors approved a new stock repurchase plan authorizing the company to repurchase up to 2.0 million shares of its common stock during the period from today through September 30, 2019. The new repurchase plan follows the February 2016 plan, which authorized the repurchase of up to 1.25 million shares, of which 1.14 million shares had been repurchased. Under the new plan, the company may purchase common stock from time to time in the open market or in privately negotiated block purchase transactions.

17:02 EDT Halcon Resources sees Q3 production 11,000-14,000 Boe/d

17:00 EDT Tetra Tech trading resumes

16:53 EDT Murphy Oil tightens FY17 production guidance to 163 to 167 Mboepd - Production for the third quarter 2017 is estimated in the range of 156 to 158 Mboepd. Third quarter guidance is below second quarter production due to pre-planned downtime work at our Sarawak oil and natural gas fields and the non-operated Terra Nova field, as well as the previously described loss of the non-operated Kodiak well in the Gulf of Mexico. There is also planned downtime at the Keyera processing plant in the Kaybob Duvernay. The temporary production loss of approximately 10,000 boepd in these four areas is partially offset by increased approximate production levels of 1,300 boepd offshore and 2,700 boepd at North American Onshore assets. The company is tightening estimated full year 2017 production guidance to be in the range of 163 to 167 Mboepd. The maintained guidance range is supported by the North American Onshore assets which are growing over 15 percent from fourth quarter 2016 to fourth quarter 2017, adjusted for divestitures. Full year capital expenditure guidance is being maintained at $890M.

16:52 EDT Vishay announces $150M share repurchase authorization - Vishay Intertechnology announced that its board has authorized a $150M stock repurchase plan. The authorization will expire on June 1, 2018.

16:49 EDT Rayonier Advanced Materials backs FY17 CapEx view roughly $60M - The Company expects net income of $32 to $39 million and EBITDA at the high-end of our initial guidance of $190 to $200 million. Cash flow from operations and adjusted free cash flows are anticipated to be $142 to $152 million and $90 to $100 million, respectively. The Company anticipates capital expenditures of approximately $60 million, including our investment in the LignoTech Florida project.

16:45 EDT CPI Card Group trading resumes

16:42 EDT Solaris Oilfield announces long-term customer contract - Solaris Oilfield Infrastructure announced a major new customer contract in connection with Solaris' strategic expansion to integrate transloading logistics with its existing operations. Under the agreement, Operator will provide minimum quarterly proppant volumes through the new facility that Solaris is developing in Kingfisher, Oklahoma. The proximity of Solaris' Kingfisher Facility to the STACK/SCOOP plays, coupled with Solaris' well site mobile proppant management systems, will allow Solaris' customers to further streamline their supply chain and reduce well completion costs. Solaris is also engaged in discussions with other large acreage holders and service providers in the STACK/SCOOP interested in establishing similar long-term agreements at the Kingfisher Facility. The Kingfisher Facility will be located central to the STACK/SCOOP plays and will be the first independent, unit-train capable, high speed transload facility in Oklahoma. The Kingfisher Facility will initially provide proppant transloading services, but will also have capacity to provide transloading services for other drilling and completion related consumables.

16:40 EDT Globus Medical announces acquisition of robotics developer KB Medical - Globus Medical announced that the acquisition of KB Medical, SA, a robotic developer based in Lausanne, Switzerland, closed during the second quarter of 2017."The acquisition of KB Medical demonstrates Globus Medical's continued commitment and enthusiasm for the potential impact of robotic technology on surgery," said Dave Demski, President, Emerging Technologies. "The addition of KB Medical will enable Globus Medical to accelerate, enhance and expand our product portfolio in Imaging, Navigation and Robotics. KB Medical's experienced team of technology development professionals, its strong IP portfolio, and shared philosophy for robotic solutions in medicine strengthen Globus Medical's position in this strategic area."

16:35 EDT Wyndham announces management structure of new companies - As two separate public companies, the vacation ownership company and the hotel company will have separate boards of directors. Holmes will serve as Non-Executive Chairman of the Board of Directors for both companies. Geoff Ballotti, current CEO of Wyndham Hotel Group, will continue to lead the hotel company as President and CEO. With more than 30 years' experience, Ballotti is well positioned to continue advancing Wyndham's leadership in the economy and midscale hotel segments, while growing the company's upscale portfolio and management business. Michael Brown, current CEO of Wyndham Vacation Ownership, will continue to lead the timeshare company as President and CEO. A 25-year industry veteran, Brown was appointed to lead the timeshare business earlier this year, bringing a strong combination of strategic vision, people-centric focus, and industry knowledge. Gail Mandel, CEO of Wyndham Destination Network, will continue to lead that business through this transition, and Tom Conforti, CFO of Wyndham Worldwide, will move into an advisory role, working with the Company through the transaction. David Wyshner will assume the role of Wyndham Worldwide CFO and will become CFO of the hotel company upon spin. Wyshner was most recently President and CFO of Avis Budget Group, the global vehicle rental service provider, and served as Avis Budget's CFO for more than ten years. Prior to that, Wyshner served as Executive Vice President and Treasurer of Cendant Corporation, a global diversified services company with approximately $20 billion in annual revenues, where Wyshner led the execution of that company's separation into three publicly traded companies. Michael Hug will serve as CFO of the timeshare company. Hug has been Executive Vice President and CFO of Wyndham Vacation Ownership since 2005. Previously, he served as Senior Vice President and Controller. Prior to joining Wyndham Vacation Ownership, Hug spent 11 years with EY.

16:32 EDT Wyndham plans to become two publicly traded companies - Wyndham Worldwide announced plans to spin off the company's hotel business resulting in two separate, publicly traded companies. Wyndham Hotel Group, with headquarters in Parsippany, NJ, will become a new, publicly traded pure-play hotel company with a portfolio of renowned brands. Wyndham Vacation Ownership, with headquarters in Orlando, Florida, will be the world's largest publicly traded timeshare company and will be joined with Wyndham Destination Network, home to RCI, the world's largest timeshare exchange company. The Company will also explore strategic alternatives for its European rental brands. The two public companies intend to enter into long-term exclusive license agreements to retain their affiliation with one of the industry's top rated loyalty programs, Wyndham Rewards, as well as continued collaboration on key inventory sharing and customer cross-sell initiatives. The corporate names of the post-spin public companies have not yet been decided. The transaction is expected to increase the fit and focus and strategic flexibility of the two post-spin companies, allow each company to maintain a sharper focus on its core business and growth opportunities, facilitate future capital raising as needed for the two companies, and position each to be better able to make the changes necessary to respond to developments in its markets. Following the planned separation, both companies will have significant scale and leadership positions within their industries, strong cash flows, rich portfolios of trusted brands, and the existing relationships in place to drive attractive growth and shareholder value. The transaction, which is expected to be tax-free to Wyndham Worldwide and its shareholders, will be effected through a pro rata distribution of the new hotel company's stock to existing Wyndham Worldwide shareholders. Wyndham Worldwide expects the transaction to be completed in the first half of 2018.

16:29 EDT Bruker announces platform and product line acquisition - Bruker announced the closing of a technology platform and product line acquisition to further expand its range of bacterial, viral and toxin detection solutions for homeland security bio-detection and for selected microbiology applications. Financial details were not disclosed. The acquired assets include intellectual property, a field-portable, electrochemical chip-based detection instrument and associated consumable kits for on-site, fast identification of selected bacteria, viruses and toxins.

16:27 EDT CenturyLink sees completion of Level 3 acquisition by end September - "We achieved our expected adjusted EBITDA for the quarter as our employees did a great job managing costs, while core revenues were below our expectations primarily due to the decline in legacy revenues and the decline in broadband units being higher than anticipated. We continue to make good progress in obtaining the necessary approvals for the pending Level 3 acquisition, having received clearance in 23 of 25 required states and territories. Integration planning is progressing well and we continue to anticipate completing the acquisition by the end of September 2017. We remain excited about the value we believe this transaction will create for our customers, our shareholders and our employees," said Glen Post, III, CenturyLink CEO.

16:26 EDT Tyson Foods streamlines organization to 'maximize growth' - Tyson Foods is streamlining its organization in support of a growth strategy announced earlier this year, the company reported today. The new structure is designed around the company's segments of Beef, Pork, Chicken and Prepared Foods."A dynamic market demands we become more agile while focusing on consumers, customers and the businesses that deliver our revenue and profit," said Tom Hayes, President and CEO of Tyson Foods. "This simple design creates individual responsibility for the performance of our segments to enable faster, better, decisions." Group presidents have been selected to lead Tyson's segments end-to-end. Each will report directly to Hayes and be responsible for growth strategy, execution and developing world class teams in all product categories and customer channels that their segments serve. The changes will take effect immediately.The executives selected to oversee the businesses include: Sally Grimes - Group President, Prepared Foods, Doug Ramsey - Group President, Poultry, Noel White - Group President, Fresh Meats (Beef and Pork) & International

16:25 EDT TakeTwo Interactive Software trading resumes

16:23 EDT Sierra Wireless trading halted, news pending

16:21 EDT Numerex trading halted, news pending

16:20 EDT Tesla sees capital expenditures of about $2B in second half - Tesla said: "Capital expenditures should be about $2B during the second half of 2017, as we make milestone-based payments for Model 3 equipment, continue with Gigafactory 1 construction, and expand our Supercharger, store, delivery hub, and service networks. While delivering the first Model 3 cars was a major company milestone, we are now focused on the critical steps to ramp Model 3 production. We remain confident in our plans and look forward to the upcoming unveiling of the next exciting addition to our portfolio of electric vehicles - Semi Truck."

16:19 EDT Tesla targeting 25% margin in 2018 - Tesla said: "The combined non-GAAP gross margin for Model S and Model X in Q3 will decline slightly from Q2, driven primarily by mix shift. Additionally, during the initial phase of the Model 3 ramp in Q3, the volume produced will be tiny relative to the installed production capacity. As a result, Model 3 gross margin in Q3 will be temporarily impacted by the excessive allocation of labor and overhead costs and depreciation over this tiny volume. In the absence of these one-time elevated cost allocations, Model 3 gross margin in Q3 would already be positive, resulting in a positive cash contribution. As capacity utilization improves, Model 3 non-GAAP gross margin is expected to be positive in Q4, and should improve rapidly in 2018 to our target of 25%. Consequently, we expect non-GAAP automotive gross margin to temporarily dip below 20% in Q3, before recovering in Q4 and beyond. For the second half of 2017, we expect strong improvement in operating leverage as revenue should significantly increase in the second half of the year as compared to the first half, while operating expenses should remain essentially flat."

16:17 EDT Tesla delivered 22,026 Model S and Model X vehicles in Q2 - Tesla said: "We produced 25,708 vehicles in Q2, 40% more cars than we built in the same period a year ago, despite a production shortfall of 100 kWh battery packs through early June. During Q2, we added more Model X cars to our test drive and display fleet because our stores had been operating with far less than what was needed and, in some cases, none at all. In addition, we increased our service loaner fleet with fully loaded cars to provide the best customer experience. This additional visibility was likely a factor in helping Model X net orders in Q2, which grew by over 20% both sequentially and as compared to Q2 2016. We delivered 22,026 Model S and Model X vehicles in Q2, for a total of 47,077 in the first half of the year. Model S and Model X combined deliveries in Q2 grew almost 53% globally versus the prior year, even though the luxury vehicle market was essentially flat."

16:16 EDT Tesla says Model 3 production on track to achieve targets - Tesla stated in its quarterly update letter: "In addition to the increased orders for Model S and Model X, customer response to Model 3 has been overwhelming. Since the handover event last week, we are averaging over 1,800 net Model 3 reservations per day. We opened the Model 3 configurator to the thousands of our employees with reservations so they could begin ordering their vehicles. Soon, non-employee customers will begin receiving invitations to order their cars in small groups based on when they placed their reservations, with existing Tesla owners receiving first priority. Deliveries to non-employees will begin in Q4...Dual Motor All-Wheel Drive configurations will be available in the U.S. early next year. International Model 3 deliveries will begin in late 2018, contingent upon regulatory approvals, starting with left-hand drive markets, followed by right-hand drive markets in 2019."

16:11 EDT BioMarin to progress two doses of Investigational Gene Therapy into Phase 3 - BioMarin will expand its development plan for BMN 270, its investigational gene therapy for hemophilia A, to include an additional Phase 3 study of the 4e13 vg/kg dose based on updated data from its ongoing open-label Phase 1/2 study of BMN 270. The Factor VIII activity levels in the 4e13 vg/kg cohort have continued to trend upwards and now support an additional Phase 3 study to the development program. Based on these updated results, BioMarin plans to initiate two separate Phase 3 studies as soon as possible, one with the 4e13 vg/kg dose and one with the 6e13 vg/kg dose. In addition, the company has commissioned its commercial gene therapy manufacturing facility and expects to start the Phase 3 program in Q4. All six patients who received a single dose of BMN 270 at 4e13 vg/kg dose had severe hemophilia A and had been treated with prophylactic Factor VIII pre-study. After receiving BMN 270 and then reaching a Factor VIII activity level above 5%, the mean Annualized Bleed Rate was reduced by 92% from 12.2 to 1.0. The median ABR for those same patients was reduced from 8.0 to zero. The mean annualized Factor VIII infusions were reduced by 97% from 144.2 to 4.8. Overall, BMN 270 has been well-tolerated by patients across all doses. The most common adverse events across all dose cohorts were alanine aminotransferase elevation; arthralgia, aspartate aminotransferase elevation, and headache; back pain and fatigue. BioMarin plans to initiate two Phase 3 studies with BMN 270, one with a dose of 4e13 vg/kg and the other with 6e13 vg/kg dose. Final determination of the design of the studies in severe hemophilia A patients is underway; the studies will each likely include fewer than 100 patients. The European Medicines Agency has granted access to its Priority Medicines regulatory initiative for BMN 270.

16:01 EDT Zumiez reports July SSS up 5.1% - Zumiez announced that total net sales for the four-week period ended July 29 increased 8.9% to $67.5M, compared to the four-week period ended July 30, 2016. The company's comparable sales increased 5.1% for the four-week period.

16:01 EDT TakeTwo Interactive Software trading halted, news pending

15:55 EDT Pandora trades higher after SiriusXM prices add-on of senior notes - SiriusXM (SIRI) announced that its subsidiary, Sirius XM Radiohas priced an offering of $250M aggregate principal amount of its 3.875% Senior Notes due 2022 and $250 million aggregate principal amount of its 5.000% Senior Notes due 2027 at an issue price of 101% of their aggregate principal amount plus accrued interest from July 5. These notes will be part of the same series as, and rank equally with, the company's 3.875% Senior Notes due 2022 and 5.000% Senior Notes due 2027 issued in July 2017. The company will receive gross proceeds of $505M from the sales of the notes before deducting the initial purchasers' commissions and offering fees and expenses. The notes will be issued to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended, and outside the United States in compliance with Regulation S of the Securities Act. Shares of Pandora (P) are off their low, still down 3%, at $8.40 per share. SiriusXM shares are down 1.6% to $5.70 per share in late day trading.

15:24 EDT Marcato Capital buys 9,100 shares of Buffalo Wild Wings - In a filing out earlier, Marcato Capital reported purchasing 9,100 shares of Buffalo Wild Wings at an average price of $109.71 per share on August 1. Shares of Buffalo Wild Wings had a volume spike and shares moved up to $112.38 after the filing. The restaurant chain's shares are up over 1.3% on the day.

15:08 EDT FDA panel votes against safety of sirukumab supporting approval - According to multiple media reports, an FDA advisory committee voted 11 to 2 that the safety profile of sirukumab is not adequate to support approval for the proposed rheumatoid arthritis indication. Johnson & Johnson (JNJ) developed sirukumab in collaboration with GlaxoSmithKline (GSK).

14:35 EDT Community Health slides after results, weak full year outlook - Shares of Community Health Systems (CYH) are sliding after the company announced second quarter results and guidance. Additionally, Community Health said it continues to receive interest from acquirers for some of its hospitals. RESULTS: Last night, Community Health Systems reported second quarter losses per share ex-items of (25c) and revenue of $4.14B, with consensus at (1c) and $4.11B, respectively. On a same-store basis, both admissions and adjusted admissions decreased 2.5%, compared with the same period in 2016. Community Health also said it expects net operating revenue, less provision for bad debts, in the range of $15.85B-$16.05B, and projects adjusted EBITDA for 2017 in the range of $1.825B-$2B. In addition to the previously announced divestiture of 30 hospitals, Community Health noted that it continues to receive interest from acquirers for certain of its hospitals. The company is pursuing these interests for sale transactions involving hospitals with a combined total of at least $1.5B in annual net operating revenues and combined mid-single digit Adjusted EBITDA margins. WEAK QUARTER: In a post-earnings note, Oppenheimer analyst Michael Wiederhorn lowered his price target for Community Health to $9 from $11 saying that the weak results reflect the company's struggle with consistency, as industry volumes remain soft and internal distractions have affected operations. Nonetheless, the analyst reiterated an Outperform rating on the shares. Meanwhile, his peer at Cantor also trimmed his price target on Community Health to $8 from $9 to reflect the latest results and the company's revised outlook. Analyst Joseph France reiterated a Neutral rating on the stock but acknowledged that he is encouraged by the company's ability to sell a number of properties. With a more focused portfolio, results could improve, he added. PRICE ACTION: In afternoon trading, shares of Community Health have dropped about 3% to $6.68.

14:07 EDT CenterPoint Energy responds to explosion in Minneapolis - CenterPoint Energy said it is responding to an explosion that occurred this morning at Minnehaha Academy in Minneapolis. "We have well-trained, experienced crews on site who are coordinating with local emergency officials to secure the area. The cause of the incident is not known at this time and we will conduct an investigation to determine the cause. Our focus at this time is making the area safe. Our thoughts are with those who have been impacted," the company stated.

13:50 EDT Cotiviti Holdings plunges lower after CFO resignation - Shares of Cotiviti Holdings, a provider of analytics-driven payment accuracy solutions, are plunging 17% in afternoon trading after reporting, Tuesday evening, that its CFO Steve Senneff was resigning to pursue a new opportunity outside of healthcare. Alongside its announcement that the CFO was leaving, the company reported Q2 EPS of 38c on revenue of $167.6M, both ahead of analyst estimates of 34c and $167.4M respectively. The company also provided FY17 estimates for revenue and adjusted EBITDA. Shares of Cotiviti Holdings are lower by 17% to $35.85 in afternoon trading.

13:31 EDT Southern Company says Scana project 'apples to oranges' to Vogtle

13:28 EDT MiMedx announces initiation of Phase 3 plantar fasciitis trial - MiMedx announced that the company has initiated its Phase 3 Plantar Fasciitis clinical study. The Company submitted a formal Investigational New Drug amendment to the Food and Drug Administration requesting the initiation of the Phase 3 trial based on the interim results of its IND Phase 2B trial for the treatment of Plantar Fasciitis. To date, the company has received no comments or changes to the amendment filing or the Phase 3 protocol, and the company is moving forward with the Phase 3 trial. MiMedx anticipates enrolling the first Phase 3 patient within the next 30 to 60 days. Approximately 164 patients will be enrolled in the study with an estimated enrollment period of 18 months. The primary efficacy endpoint will be the change in Visual Analog Scale score for patients between baseline and Day 90 expressed as the difference in means between the AmnioFix Injectable versus placebo-treated group. The primary safety endpoint will be the incidence of Adverse Events, Serious Adverse Events, and Unanticipated Adverse Events during the first 180 days post injection in the AmnioFix Injectable group versus the placebo-treated group.

13:24 EDT Southern Company sees 8c-10c ongoing EPS reduction from Kemper plant - Says eyeing third party tax equity to fund renewables for Southern Power. Says would require more debt and equity to finish Vogtle units. Says has accounted for probable outcome for Kemper projects. Sees ongoing reduction to ongoing EPS 8c-10c per share from Kemper plant.

13:12 EDT Boeing, Spirit AeroSystems reach long-term supplier agreement - Boeing (BA) said it has reached an agreement in principle with its largest supplier, Spirit AeroSystems (SPR), which builds significant structures and components for all five Boeing Commercial Airplanes programs. Boeing says in a statement: "This is another important step forward for Boeing's Partnering for Success program, our collaborative effort with suppliers to reduce costs, improve efficiency and position our products and services to compete in today's aerospace market. This agreement, when finalized, will also provide additional stability to our commercial programs and is part of our ongoing strategy to retire risk from our business. We commend Spirit for making a long-term commitment to improve affordability and deliver high quality in their manufacturing for Boeing."

13:10 EDT AbbVie announces FDA approval of Imbruvica for adults with cGVHD - AbbVie (ABBV) announced the U.S. FDA has approved IMBRUVICA for the treatment of adult patients with chronic graft-versus-host-disease, or cGVHD, after failure of one or more lines of systemic therapy. With this approval, IMBRUVICA becomes the first and only therapy specifically approved for adults with cGVHD, a serious and debilitating potential consequence of stem cell or bone marrow transplant.2 IMBRUVICA, a first-in-class Bruton's tyrosine kinase inhibitor, is jointly developed and commercialized by Pharmacyclics LLC, an AbbVie company, and Janssen Biotech (JNJ). The approval in cGVHD is based on findings from an open-label, multi-center, single-arm Phase 1b/2 trial, which evaluated the safety and efficacy of ibrutinib in 42 patients with cGVHD that failed to respond to first-line corticosteroid therapy and required additional therapy. IMBRUVICA has been granted four Breakthrough Therapy Designations from the FDA, including in cGVHD. IMBRUVICA is now approved for six indications overall, including adult patients with cGVHD that failed to respond to one or more lines of systemic therapy, as well as adults with certain types of non-Hodgkin's lymphomas, including CLL/small lymphocytic lymphoma, including patients with 17p deletion.

13:04 EDT Sevcon sees revenue from new services contracts approximately $4.8M - Sevcon reported that it has started shipments to a Chinese automotive manufacturer, supplying its Gen5 based controller. The production shipments commenced in July. The Company estimates that if the customer's production schedule advances according to plan, the contract would be worth up to $40M in revenue to Sevcon over the life of the program, which runs through 2021. The company also announced new orders from three European high-performance automobile manufacturers. The first of the three orders is to provide engineering services for the development of another hybrid supercar, the second provides engineering and hardware supply for Formula E work and the third provides engineering and pre-production services for electric vehicles. In sum, revenues from these engineering services contracts are estimated at approximately $4.8M. Assuming successful development, start of production for all three OEMs would begin in 2018 and end in 2021.

12:48 EDT Hilton Food Group says in early stage talks related to potential acquisition - In a statement to the London Stock Exchange, Hilton Food Group said it notes the media speculation in relation to a potential acquisition and confirms that it is at an early stage of discussions in relation to such a transaction. There can be no certainty at this time whether any agreement on such transaction will be reached, and a further announcement will be made as and when appropriate. Companies in the packaged foods space include General Mills (GIS), Kellogg (K), Hershey Foods (HSY), Kraft Heinz (KHC) and Campbell Soup (CPB), which are all moving higher this afternoon. Reference Link

12:34 EDT Enviva raises quarterly dividend 8.6% to 57c per share - Enviva Partners announced that the board of directors of its general partner declared a quarterly distribution of 57c per common and subordinated unit for the second quarter of 2017. This distribution is 8.6% higher than the distribution for the second quarter of 2016. The quarterly distribution will be paid on Tuesday, August 29 to unitholders of record as of the close of business on Tuesday, August 15.

12:05 EDT Qualcomm enters into license agreement with EyeLock - EyeLock, a majority owned subsidiary of VOXX (VOXX), announced that it has entered into a license agreement with Qualcomm Technologies, a subsidiary of Qualcomm (QCOM), for Qualcomm Mobile Security. EyeLock is developing iris authentication solutions that are designed to work with Qualcomm Mobile Security and enable OEMs across the entire IoT spectrum to benefit from one of the most secure iris authentication implementations available.

12:01 EDT Crown Crafts Infant Products signs licensing pact with ED Ellen Degeneres - Crown Crafts Infant Products, Inc., a wholly owned subsidiary of Crown Crafts, announced that it has entered into a licensing agreement with ED Ellen DeGeneres. Under the agreement, Crown Crafts will market and distribute a new line of infant bedding, blankets, bibs and bath products carrying the ED brand name.

11:37 EDT FDA expands approval of Imbruvica to chronic graft versus host disease - The U.S. Food and Drug Administration announced it has expanded the approval of Imbruvica for the treatment of adult patients with chronic graft versus host disease, or cGVHD, after failure of one or more treatments. This is the first FDA-approved therapy for the treatment of cGVHD, the agency noted. The FDA granted the approval of Imbruvica to Pharmacyclics. Imbruvica is jointly developed and commercialized by AbbVie (ABBV) and Johnson & Johnson's (JNJ) Janssen.

11:32 EDT PayPal and Microsoft's Skype launch Send Money feature - Skype (MSFT) and PayPal (PYPL ) team up with new Send Money feature. Reference Link

11:25 EDT Mark Cuban targets price of Biogen's Spinraza in tweets - Mark Cuban on Twitter highlighted yesterday's report from the NPR Science Desk on the price of Biogen's (BIIB) spinal muscular atrophy treatment Spinraza. The drug costs $750,000 for the initial year of treatment. Cuban tweeted, "Drug Puts A $750,000 'Price Tag On Life' n.pr/2uKx4RE. Don't blame @biogen blame CEO- Michel Vounatsos & Ionsis's Stanley Crooke." Ionis Pharmaceuticals (IONS), which is down 64c to $50.30 in late morning trading, receives royalties from Biogen's sales of Spinraza. Reference Link

11:16 EDT Diamondback Energy says confident it will execute on forecast

11:10 EDT SeaWorld slides as CFO departs amid DOJ, SEC probes - Shares of SeaWorld (SEAS) dropped in morning trading after the company said its chief financial officer will leave to join another company. The news adds to SeaWorld's woes, following recent reports of federal investigations linked to the "Blackfish" documentary and the death of baby killer whale Kyara. CFO DEPARTURE: SeaWorld announced that CFO Peter Crage is leaving the company "to assume a senior-level financial position at another company." Marc Swanson has been appointed interim CFO and treasurer, effective immediately. Swanson has served as SeaWorld's chief accounting officer since 2012, and served as interim CFO in 2015. He will continue to serve as chief accounting officer, SeaWorld said, adding that Crage will remain with SeaWorld through August to ensure a smooth transition. Crage has served as CFO since September 1, 2015. WHAT'S NOTABLE: In June, SeaWorld disclosed that it received subpoenas from the Department of Justice and Securities and Exchange Commission regarding its response to "Blackfish," a documentary critical of the company's treatment of killer whales. The investigations were in connection with "disclosures and public statements made by the company and certain executives and/or individuals on or before August 2014, including those regarding the impact of the 'Blackfish' documentary, and trading in the company's securities." SeaWorld also said its board formed a special committee comprised of independent directors with respect to the inquiries. In July, SeaWorld said that three-month old killer whale Kyara, the last killer whale to be born in captivity at SeaWorld, died after serious health problems, including what was likely pneumonia. Earlier this week Dealreporter said that the amusement park operator added Evercore as a second financial advisor, joining incumbent JPMorgan. Evercore is "going to bring a fresh perspective" on how to deal with the dual issues of weakening operational performance and a "highly engaged" activist shareholder, the report said, according to contacts. ANALYST COMMENTARY: Stifel analyst Steven M. Wieczynski told clients in a note that the CFO news is "positive," as investors believe that Crage did not effectively manage expectations for the company's results. Additionally, the analyst said he is pleased that the company's CEO will be able to appoint the CFO of his choice. The analyst maintained a $23 price target and a Buy rating on SeaWorld shares. SunTrust analyst Michael Swartz said yesterday that SeaWorld can either sell itself or monetize its regional parks. He also noted that the two major shareholders, which own a total of roughly 35% of the company, could be an obstacle to any deal, and said that Dealreporter's report could make shareholders question the success of the company's turnaround plan. PRICE ACTION: SeaWorld is down 4.2% to $14.63 in morning trading. Shares are down 22% year-to-date. OTHERS TO WATCH: Other theme park operators include Cedar Fair (FUN) and Six Flags (SIX), both of which are lower this morning.

11:02 EDT Tyler Technologies acquires Digital Health Department - Tyler Technologies announced it has acquired the assets of Digital Health Department, a company that provides environmental health software, offering a software-as-a-service solution for public health compliance and inspections processes. With this acquisition, Tyler will broaden its EnerGoventerprise licensing and regulatory solution by adding environmental health-market-focused inspections and a compliance offering. The offering aids local and state governments with managing the critical processes of protecting the community's public health, related to the programs of health and environmental compliance and inspections of food and restaurant, pool and recreational health, wastewater and septic, drinking water, solid wastes, hazardous materials, vector control, daycare, tattoo and body art, tourist accommodations, campgrounds, and other services.

10:37 EDT Standex acquires privately-held Piazza Rosa Group; terms not disclosed - Standex announced that it has acquired Italy-based Piazza Rosa Group, a provider of mold and tool treatment and finishing services for the automotive and consumer products markets. Privately held Piazza Rosa Group reported consolidated revenues of EUR9.4M for the year ended December 31, 2016. The acquisition is expected to be accretive to EPS of 2c-3c in fiscal year 2018 and 6c-7c in fiscal year 2019, excluding purchase accounting and acquisition costs. Piazza Rosa's senior management team will be continuing with the company. Other terms of the transaction were not disclosed.

10:32 EDT Apple rises as guidance seen easing iPhone 8 launch worries - This morning, several Wall Street analysts raised their price targets on Apple (AAPL) shares following the company's better than expected third quarter results. Many also argued that Apple's guidance for the fourth quarter seems to imply that fears of an iPhone 8 launch delay or limited availability may have been overblown. RESULTS: Last night, Apple reported third quarter earnings per share of $1.67 and revenue of $45.4B, both above consensus of $1.57 and $44.89B, respectively. The company also said that it sees fourth quarter revenue of $49B-$52B and gross margin between 37.5%-38%. IPHONE 8 FEARS OVERBLOWN: In a post-earnings research note, Piper Jaffray analyst Michael Olson raised his price target for Apple to $190 from $158 following the better than expected June quarter results. The analyst told investors that the company's outlook implies that fears of an "iPhone X" launch delay, and/or limited availability of the device, may have been "overblown." He believes most investors had grown concerned that an iPhone X delay would hamper the outlook, but it did not prove to be the case. Olson recommended owning Apple due to growing anticipation around the new iPhone and a favorable trajectory for services revenue. RBC Capital analyst Amit Daryanani also upped his target for Apple to $176 from $168, saying that the "material surprise" was a strong September-quarter guide that effectively implies "NO iPhone launch delay" despite myriad of commentary to the contrary. Moreover, Daryanani argued that he thinks Apple remains on-track to become the first company to achieve $1T market cap, and should sustain an upside bias through and potentially beyond the next iPhone launch this September. He reiterated an Outperform rating on the shares. Additionally, UBS analyst Steven Milunovich, Needham analyst Laura Martin, Credit Suisse analyst Kulbinder Garcha, Citi analyst Jim Suva, Loop Capital analyst Ananda Baruah, Macquarie analyst Benjamin Schachter, JPMorgan analyst Rod Hall, and Barclays analyst Mark Moskowitz raised their targets on Apple's shares this morning. POSITIVE FOR SUPPLIERS: Also commenting on the company's announcement, Oppenheimer analyst Rick Schafer noted that he expects Apple's supply chain to react positively to the company's results as guidance likely implies limited impact from any possible launch/production delays. Within the iPhone maker's supply chain, his top picks are content-driven growth stories Broadcom (AVGO) and Skyworks (SWKS). Schafer remains on the sidelines on Cirrus Logic (CRUS) and Qorvo (QRVO) heading into their respective prints tomorrow. PRICE ACTION: In morning trading, shares of Apple have gained 4.4% to $156.65.

10:28 EDT Groupon expects customer adds to trend up in 2H vs. Q2

10:20 EDT Meritor raises FY17 free cash flow guidane to $80-$90M - Guidance provided on Q3 earnings conference call.

10:07 EDT FMC Corporation says plans to list FMC Lithium in 2H18 - The company says it intends to create two independently listed public companies with positions in their respective industries. Expects to move toward a separate listing of FMC Lithium in the 2H18. Expects to announce a final decision on the timing by Q2.

10:01 EDT Comtech awarded $7.5M order for SSPAs - Comtech announced that during its fourth quarter of fiscal 2017, its Santa Clara, California-based subsidiary, Comtech Xicom Technology, which is part of Comtech's Commercial Solutions segment, received an order for $7.5M for Solid-State Power Amplifiers to be used in an airborne, In-Flight Connectivity application. This order will be shipped in fiscal 2018. These Gallium Nitride SSPAs will enable high-speed satellite connectivity for both airlines and travelers around the world.

09:27 EDT Humana sees 'steady' EPS growth in FY18, membership growth

09:22 EDT Humana says ACA plans expected to post $85M profit this year vs. prior outlook - Humana said it raised its FY17 adjusted EPS view due to the strong results in the retail segment, primarily the company's individual Medicare Advantage business. Humana said the individual Medicare Advantage business is "exceeding its operational targets," experiencing lower than anticipated utilization, higher than expected revenue on a per member basis and favorable medical fee-for-service claims reserve development. Humana said it is looking to expand primary and home care platforms for Medicare members, sees some organic growth, "some areas will require M&A." Says CMS star scores is complex, expects 74% 4-star or higher membership for 2018. Says working on better engagement, "eliminating friction points" for members has helped improve net promoter score. Expects Q3 to reflect adjusted EPS in high 20% range, Q4 comprising percentage in high teens. Says ACA plans expected to post $85M profit due to lower costs, risk adjustment and reinsurance payments; Humana previously forecast losing $45M on ACA compliant business. Sees repurchasing shares for rest of year. Says capacity for cash M&A is approx. $3.5B. Comments taken from the Q2 earnings conference call. Humama is up nearly 4% in premarket trading.

09:16 EDT On The Fly: Pre-market Movers - UP AFTER EARNINGS: Apple (AAPL), up 6%... Illumina (ILMN), up 10.9%... Hanesbrands (HBI), up 4.2%... FireEye (FEYE), up 7.4%... Humana (HUM), up 3.9%... FMC Corporation (FMC), up 4.7%. DOWN AFTER EARNINGS: AutoNation (AN), down 6%... Sodastream (SODA), down 3.8%... Groupon (GRPN), down 2.3%... Herbalife (HLF), down 4.9%.

09:11 EDT Wipro partners with Tricentis for Quality Engineering - Wipro and Tricentis announced a partnership for Quality Engineering. This partnership with Tricentis will strengthen Wipro's Quality Engineering and Testing Services capabilities by integrating Tricentis Tosca, a continuous testing platform, with Wipro AssureNXT, a managed services QA platform combined with the capabilities of Wipro HOLMES Artificial Intelligence Platform as a part of the broader automaton ecosystem. The Wipro - Tricentis partnership will enable clients to successfully achieve their business outcomes in today's digital landscape by enabling continuous integration, delivery and in turn, DevOps. The joint offering will also help improve time-to-market and quality by augmenting end-to-end automation across the software testing lifecycle. Along with the partnership agreement, Wipro Ventures, the strategic investment arm of Wipro Limited, has made an investment in Tricentis, as part of their most recent funding round.

09:05 EDT Grainger Chairman of the Board Jim Ryan retiring, succeeded by CEO Macpherson - Grainger has named DG Macpherson, Grainger CEO, to assume the additional role of Chairman of the Board, effective October 1, upon the retirement of Jim Ryan, Board Chairman. Macpherson's appointment to Chairman is part of the succession plan highlighted in August of last year, when Macpherson was named CEO. Macpherson joined Grainger in 2008 after working on behalf of Grainger for six years as a partner and managing director at Boston Consulting Group.

09:03 EDT Lockheed Martin invests $350M in satellite production facility - Lockheed Martin has begun preliminary construction on a new, $350M facility that will produce next-generation satellites. The new facility is located on the company's Waterton Canyon campus near Denver and is slated for completion in 2020. Lockheed Martin expects the construction effort to employ a total of 1,500 contractors during the three-year construction phase. Lockheed

09:00 EDT Advaxis to present at third CRI-CIMT-EATI-AACR conference - Advaxis announced three abstracts were selected for presentation at the third annual CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival. The prestigious program brings together leading stakeholders in the field to teach, learn and disseminate the latest cutting-edge information and research in cancer immunology and immunotherapy. Two poster presentations will feature preliminary immune correlative data from the ADXS-PSA monotherapy treatment arm of Advaxis' Phase 1/2 study in combination with KEYTRUDA in metastatic castration-resistant prostate cancer patients. The third presentation will feature preclinical data with the company's HPV-targeted immunotherapy, axalimogene filolisbac. The poster presentation, "Gene expression profiles associated with stable disease in metastatic castration-resistant prostate cancer patients treated with ADXS-PSA immunotherapy," will feature preliminary data identifying potential pharmacodynamic biomarkers of clinical response in mCRPC patients treated with ADXS-PSA monotherapy. The second poster presentation, "Persistence of expanded TCRbeta clonotypes is associated with clinical activity of ADXS-PSA immunotherapy in metastatic castration-resistant prostate cancer," will focus on the stability of expanded T cell clones in mCRPC patients following treatment with ADXS-PSA monotherapy. The preliminary immune correlative data will be presented by Sandy Hayes, Ph.D., Senior Director of Research and Biomarker Lead at Advaxis. The third poster presentation, "Identification of an intratumoral immune gene signature associated with tumor regression in an axalimogene filolisbac-treated murine HPV+ tumor model," will include preclinical data regarding molecular biomarkers associated with tumor regression in a murine HPV+ tumor model. It will be presented by Rachelle Kosoff, Ph.D., Senior Scientist in Research at Advaxis.

08:50 EDT Lilis Energy says SEC civil complaint against CEO unrelated to Lilis business - Lilis Energy disclosed in a regulatory filing that on August 1 the SEC filed a civil complaint against multiple parties, including Lilis CEO Abraham Mirman. The company stated: "The allegations in the complaint are unrelated to the business of Lilis Energy and predate Mr. Mirman's tenure with the Company. We understand that Mr. Mirman denies the Commission's allegations, and intends to vigorously defend this matter. The Board of Directors of the Company will continue to evaluate this matter and any future developments as necessary."

08:48 EDT CBOE Holdings and Gemini enter into license agreement for Bitcoin market data - CBOE Holdings and Gemini Trust Company announced an agreement that provides Chicago Board Options Exchange and its affiliates with an exclusive global license to use Gemini's bitcoin market data for bitcoin derivatives and indices. Gemini is a digital asset exchange and custodian that allows customers to buy, sell, and store digital assets such as bitcoin and ether. Under the terms of the agreement, CBOE will have a multi-year exclusive global license permitting it to use Gemini's market data, including Gemini daily bitcoin auction values, in the creation of bitcoin derivatives products for listing and trading. Cash-settled bitcoin futures are planned to be made available for trading on CFE in Q4 or early 2018. Moreover, CBOE will retain exclusive rights to use Gemini market data for the creation of new indexes, as well as rights to distribute Gemini market data over CBOE's market data feeds. Over the last five years, the total value of all bitcoin outstanding has grown from less than $1b to nearly $50B.

08:43 EDT Groupon says international turnaround 'taking a few more quarters' than expected - Reports Q2 headcount of 6.661, down 615 y.y. Expects SG&A to be lower in the second half of 2017 compared to the first half. Plans to maintain 12-18 month payback of incremental spend on gross profit. Expects to generate significant positive FCF in 2017. Sees potential towards the lower end of $1.30B-$1.35B gross profit range due to International turnaround taking a few more quarters than expected and loss of gross profit from exiting food delivery operations. Comments from slides that will be presented on the Q2 earnings conference call. Groupon is down 2.6% in premarket trading.

08:39 EDT Neuralstem awarded grant by NIH for NSI-189 preclinical research - Neuralstem announced that it has been awarded a Phase 2 Small Business Innovation Research grant by the National Institutes of Health of up to $997,068 over two years to conduct preclinical research to evaluate the potential of NSI-189, a novel small molecule compound, for the prevention and treatment of diabetic neuropathy. TThe research funded by this award will build on a previous study performed in collaboration with Drs. Corinne Jolivalt's and Nigel Calcutt's groups at the University of California, San Diego, that demonstrated NSI-189 could prevent and/or reverse peripheral neuropathy in mouse models for Type 1 and Type 2 diabetes. NSI-189 was shown to significantly protect motor and sensory nerve function in mice with Type 1 diabetes when given from onset of disease, and improve nerve function when given 2 months after disease onset. Similarly, NSI-189 protected motor and sensory nerve function in a genetic model of Type 2 diabetes.

08:35 EDT BioTime unit AgeX Therapeutics obtains $10M in capital, commences operations - AgeX Therapeutics, a subsidiary of BioTime, reported that it has successfully raised $10M in equity financing to fund its operations. Following the financing, BioTime continues to own about 87% of AgeX's outstanding shares. The financing is expected to fund preclinical development at AgeX as well as building the company's operational infrastructure. The financing may also lead to a registration and distribution of a to-be-determined percentage of the AgeX shares to BioTime shareholders, after which AgeX would trade as a public company.

08:34 EDT Groupon raises bottom end of FY adjusted EBITDA view to $215M-$240M - Groupon is updating its outlook for 2017, which reflects current foreign exchange rates, as well as expected marketing investments and cost benefits associated with streamlining initiatives. The basis for our full year 2017 guidance is continuing operations. For the full year 2017, Groupon expects gross profit to be in the range of $1.3B-$1.35B, which is unchanged. Groupon is raising the bottom end of its expected Adjusted EBITDA guidance range to $215M-$240M in 2017.

08:32 EDT Kite Pharma doses first patient in Phase 2 trial of axicabtagene ciloleucel - Kite Pharma announced that patients with relapsed/refractory indolent B-cell non-Hodgkin lymphoma are now being treated in its Phase 2 ZUMA-5 trial with its lead investigational candidate, axicabtagene ciloleucel. This study builds upon early clinical results using the same axi-cel anti-CD19 construct previously published in the March 2012 issue of Blood, "B-cell Depletion and Remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells," in which patients with relapsed/refractory iNHL experienced a high response rate and durable disease remissions in a clinical trial at the National Cancer Institute. ZUMA-5 is a single-arm, open-label, multi-center study in patients with iNHL whose disease has relapsed within two years of first line treatment, is refractory to second line or greater therapy or has relapsed at any point after transplant. The study will enroll approximately 50 patients. Additional details about this study can be found on ClinicalTrials.gov, using identifier NCT: 03105336.

08:17 EDT Spherix issues letter to shareholders - Spherix issued a letter to shareholders. The letter states, among other things: "(...) We are extremely excited about our investment in Hoth Therapeutics, a biopharmaceutical company that is developing therapeutics for patients suffering from eczema. Our company's efforts are focused on moving Hoth into a Phase 2 study and providing additional infrastructure support. (...) Under the negotiated terms of the Hoth transaction, our monetary investment in Hoth is fixed and we do not anticipate additional funding from Spherix to develop this unique compound. (...) We are confident that Hoth will develop the BioLexa platform without additional funding from us. (...) BioLexa is not an untested compound. (...) Spherix believes that these positive test results, from a well-known and respected medical institution, supports the exciting development prospects for this compound. (...) Finally, we have been working with Equitable IP on vetting new, mostly unlicensed, optical patents acquired earlier this year as part of a licensing deal. (...) Our preliminary work has identified at least eight patents that show promising infringement potential. We are working with Equitable to implement a monetization strategy around these new patents and hope to see new cases on file soon. (...) our unique relationship with Equitable allows us to monetize these intellectual property assets without incurring litigation costs. (...) We have reduced our year over year cash burn, while continuing our patent monetization efforts. (...)"

08:11 EDT MEI Pharma and Helsinn Group dose firs patient in Phase 3 study of pracinostat - MEI Pharma and Helsinn, a Swiss pharmaceutical group focused on cancer care products, have dosed the first patient in the pivotal Phase 3 study of the investigational agent pracinostat in combination with azacitidine in adults with newly diagnosed acute myeloid leukemia who are unfit to receive intensive induction chemotherapy. The study will enroll approximately 500 eligible patients worldwide. The primary endpoint of the study is overall survival. Secondary endpoints include, among others, morphologic complete remission rate, event free survival and duration of CR.

08:07 EDT Ares Capital purchases remaining SSLP loans, concludes JV - Ares Capital announced that it has closed on a definitive agreement under which Ares Capital purchased the remaining loans of the Senior Secured Loan Fund LLC, effectively concluding the joint venture. Under the terms of the agreement, Ares Capital purchased the remaining $1.6B portfolio of first lien senior secured loans outstanding at par plus accrued and unpaid interest and fees from the SSLP. Following the completion of the loan sale, the SSLP made a final distribution of $1.7B to the SSLP subordinated certificates, of which Ares Capital received approximately $1.5B. Over the life of its investment in the SSLP, Ares Capital generated a gross IRR of 20%. As a result of this agreement, Ares Capital increased its investment in first lien senior secured loans by $1.6B, yielding approximately 7.1% in the aggregate, and exited the remaining $1.5B of SSLP subordinated certificates, which were yielding approximately 5.75% at closing.

08:05 EDT R1 RCM appoints Gary Long as Chief Commercial Officer - R1 RCM announced the appointment of Gary Long to the newly created role of Executive Vice President and Chief Commercial Officer. Most recently, he was Senior Vice President and Chief Sales Officer at Premier.

08:03 EDT American States Water announces 5.4% increase in quarterly dividend to 25.5c - On August 1, the Board of Directors of American States Water Company approved an increase in AWR's third quarter cash dividend from 24.2c to 25.5c per share on the common shares of the company. The annualized dividend rate after this increase is $1.02 per share, which represents a 5.4% increase from the current annualized dividend rate of 96.8c per share. This action marks the 325th consecutive dividend payment by the company. For 63 consecutive years, American States Water Company shareholders have received an increase in their aggregate annual dividend. Dividends on the common shares will be payable on September 1, 2017 to shareholders of record at the close of business on August 15, 2017.

08:02 EDT Vulcan Materials sees FY17 adjusted EBITDA $1.05B-$1.13B - Regarding the company's earnings outlook for 2017, CEO Hill stated, "We are excited about the growth opportunities ahead of us. Leading indicators, such as growth in the pre-construction pipeline and in construction starts in our markets, as well as growth in our own order backlogs, point toward a return to growth in the second half of this year and beyond. However, the rate of growth through the remainder of this year will depend on the pace at which our customers catch up on deferred work and on the timing of our shipments to large projects in our backlog. Given these factors and the significant shortfall to plan experienced in the second quarter, we have revised our outlook for shipments to between 182 and 187 million tons. Primarily due to this lower expectation for 2017 aggregates shipments, we now project full year Adjusted EBITDA of between $1.05 and $1.13 billion. Other management expectations (e.g. aggregates price improvement, asphalt and concrete gross profit growth, SAG expense, capital spending, and effective tax rate) remain as outlined in our fourth quarter 2016 earnings communication."

08:01 EDT TiVo to bring personalized entertainment to Service Electric customers - TiVo Corporation and Service Electric Cable TV announced that the companies will bring the "ultimate personalized entertainment experience to Service Electric customers powered by the latest TiVo Gateway DVR solution."

07:52 EDT Diana Containerships announces receipt of Nadsaq notice - Diana Containerships announced that it has received written notification from The Nasdaq Stock Market LLC dated July 31, 2017, indicating that the company is no longer in compliance with the continued listing requirements because the market value of publicly held shares was below $5,000,000 for 30 consecutive business days. Under Nasdaq rules, publicly held shares is defined as total shares outstanding, less any shares held directly or indirectly by officers, directors or any person who is the beneficial owner of more than 10% of the total shares outstanding of the company. The company intends to monitor its MVPHS during the prescribed grace period and is considering all options that will allow its common shares to remain listed on Nasdaq. During this time, the company's common shares will continue to be listed and trade on The Nasdaq Global Select Market. The company's business operations are not affected by the receipt of the notification.

07:41 EDT Sinclair Broadcast CEO sees Q3 core advertising 'flattish' - "Although we expect core advertising to be flattish in the third quarter due in part to the absence of $11 million in Olympic advertising revenues received in third quarter of 2016, adjusting for the for-profit technical schools that went out of business in 2016, core advertising would be flat to up low single digit percents," commented Chris Ripley, President and CEO. "Our digital business, excluding new digital investments, continues to outperform with mid to high twenty percent growth expected in the third quarter of 2017. On the cash flow front, in July, we received approximately $311 million of gross proceeds from the FCC Spectrum Auction, which we intend to use towards the funding of the Tribune acquisition."

07:39 EDT Dominion declares quarterly distribution of 28.8c per unit - Payable on Aug. 15 to such unitholders of record at the close of business Aug. 4. This distribution represents a 5% increase over last quarter and supports the company's 22% annual distribution growth rate plan.

07:37 EDT Crocs extends partnership with Drew Barrymore - Crocs announced a product collaboration on a line of special-edition footwear styles for women and children, designed in partnership with Drew Barrymore. The Drew Barrymore Crocs line will launch globally in the spring of 2018, combining the comfort and bold colors consumers love about Crocs with touches of Barrymore's personal design style - including exclusive graphics and embellishments.

07:33 EDT Clean Harbors continues to see FY17 adjusted EBITDA $435M-$475M - "Looking ahead to the second half of 2017, we expect our top-line momentum to continue, led by Technical Services and Safety-Kleen. For Technical Services, we see promising trends in U.S. Industrial Production and GDP, particularly in some of our key verticals. Our pipeline of base work and project opportunities continues to grow. With our new El Dorado incinerator fully operational, we expect volumes in our incineration network to increase as the year progresses, driven by the Chemical and Retail markets. Within Safety-Kleen, our closed loop offering will deliver incremental growth in 2017 as we expand into additional markets with our bulk lubricants offering," McKim continued. "Base oil and lubricant prices are expected to remain stable in the near-term. As evidenced by our recent announcement regarding our Charge-for-Oil rates and stop fees, we will continue to carefully manage the spread in our re-refinery business. We also intend to make ongoing investments in areas of Safety-Kleen that we expect to deliver long-term value as we steadily grow our direct sales business in the quarters and years ahead. We believe that our profitable growth initiatives, combined with signs of improvement in macroeconomic conditions and our ongoing cost-reduction programs, set the stage for a strong second half of the year. As a result, we remain on track to achieve our full-year guidance."

07:31 EDT AutoNation cites implementation challenges with centralized One Price strategy - AutoNation Chairman, CEO and President Mike Jackson said, "Our pre-owned margins declined due to implementation challenges with our centralized One Price strategy during the quarter. However, we've taken decisive action to resolve those issues by realigning our leadership and structure to fully realize the opportunity of our brand extension strategy." AutoNation continues to move forward with its comprehensive brand extension strategy. Since January 1, 2017, AutoNation has opened two auto auctions in Orlando, FL, and Houston, TX, and acquired three collision centers in Ft. Lauderdale, FL, Bellevue, WA, and Lewisville, TX. The Company currently owns and operates 72 AutoNation Collision Centers from coast to coast. AutoNation Precision Parts and AutoNation Auto Gear remain on track, with multiple parts categories expected to be available at our AutoNation USA stores, collision centers, and auctions by year-end, the company said.

07:26 EDT Compugen appoints Paul Sekhri as new Chairman of the Board - Compugen has appointed Paul Sekhri to serve as a Director and Chairman of the Board, effective October 2. As the new Chairman, Sekhri will succeed Martin Gerstel, who announced his intention to retire from this role in February of this year. Sekhri is currently a member of the Board of Directors of Veeva Systems, Chairman of the Board of Supervisory Directors of Pharming N.V. and Topas Therapeutics GmbH, and was recently nominated as Chairman of the Board of Petra Pharma.

07:23 EDT Main Street increases monthly cash dividend 3% to 19c per share - Main Street declared regular monthly cash dividends of 19c per share for each of October, November and December. These monthly dividends total 57c per share for Q4 and represent a 3% increase from both the regular monthly dividends paid for 4Q16 and the regular monthly dividends declared for 3Q17. The October dividend is payable on October 16th to shareholders on record as of September 21.

07:22 EDT Mondelez increases quarterly dividend 16% to 22c per share - The company repurchased approximately $600M of its common stock and paid approximately $300M in cash dividends. The company's Board of Directors also declared a quarterly cash dividend of 22c per share, an increase of 16%.

07:19 EDT Mondelez says Dirk Van de Put to succeed Irene Rosenfeld as CEO - Mondelez International announced that its Board of Directors has unanimously selected Dirk Van de Put, current President and CEO of McCain Foods, to succeed Irene Rosenfeld as CEO of Mondelez International, as she steps down effective November 2017. Van de Put will also join the company's Board of Directors. Rosenfeld will continue as Chairman of the Board until March 31, 2018, at which point she will retire and Van de Put will assume the role of Chairman and CEO.

07:18 EDT GMS Inc. acquires ASI Building Products; terms not disclosed - GMS Inc. announced the acquisition of the Michigan-based ASI Building Products. ASI is a provider of ceilings and other quality building products serving the Eastern Michigan market through three locations: Saginaw, Southfield and Detroit. ASI distributes interior building products for residential and commercial projects of all sizes.

07:13 EDT On Deck Capital partners with Payment Source in Canada - OnDeck announced a partnership with Payment Source, the largest retail distribution network for prepaid products in Canada, to offer Payment Source's Now Prepay customers access to the OnDeck online small business lending platform. Payment Source operates the Now Prepay brand and provides prepaid mobile top ups, gift cards and financial products and services to more than 15,000 retailers throughout Canada.

07:11 EDT FIS approves $4B share repurchase authorization - The company is announcing that its board of directors has approved a new $4B share repurchase authorization, effective through December 31, 2020. The company's revised full-year 2017 adjusted EPS guidance does not anticipate any share repurchase impact.

07:11 EDT PharMerica withdraws previous FY17 financial guidance - The company is withdrawing the previous financial guidance for fiscal 2017 and has suspended any further updates as a result of the pending transaction.

07:07 EDT Theravance announce Phase 2b results of velusetrag in gastroparesis - Theravance Biopharma announced "positive" results from a 12-week, Phase 2b study of velusetrag, an oral investigational drug in development for the treatment of patients with diabetic and idiopathic gastroparesis. Top-line results from the study demonstrated statistically significant improvements in gastroparesis symptoms and gastric emptying in patients receiving 5 mg of velusetrag as compared to placebo, the company said. Additionally, velusetrag was shown to be generally well-tolerated, with 5 mg and placebo having comparable rates of adverse events and serious adverse events, Theravance added. The study was conducted in 232 patients with either diabetic or idiopathic gastroparesis who received either velusetrag or placebo, administered orally as a once daily dose. After four weeks of dosing, when the primary assessments were made, patients in the 5 mg velusetrag treatment arm demonstrated statistically significant improvements in symptom scores compared to placebo in two separate patient reported outcome tools: the Gastroparesis Cardinal Symptom Index and the Gastroparesis Rating Scale. The primary endpoint analysis included a pre-specified analysis of each dose against placebo to report nominal p-values. The analysis also included multiplicity adjustments of p-values to account for three dose comparisons to placebo. Patients in the 15 and 30 mg velusetrag study arms did not demonstrate nominally statistically significant improvements in gastroparesis symptoms versus placebo, possibly due to an increased frequency in gastrointestinal side effects at these doses that may have been caused by rapid emptying of the stomach. The lack of dose response resulted in a lack of statistical significance across the three doses when adjusted for multiplicity. As a result, the statistical comparisons for the 5 mg dose are not adjusted for multiple comparisons, and all are quoted as nominal. "We believe that these findings provide clear evidence of the potential benefit of velusetrag in patients with gastroparesis, a debilitating disease in significant need of therapeutic innovation," said Brett Haumann, MD, Chief Medical Officer of Theravance Biopharma. "We are now preparing to meet with regulators to discuss the next phase in our development plan."

07:04 EDT Molson Coors says 'on track' to deliver FY business plans, cost savings targets

07:02 EDT PharMerica agrees to be acquired by KKR in deal valued at approx. $1.4B - PharMerica (PMC) announced that it has entered into a definitive merger agreement pursuant to which a newly formed company controlled by KKR (KKR), with Walgreens Boots Alliance (WBA) as a minority investor, will acquire PharMerica. The all-cash transaction is valued at approximately $1.4B including the assumption or repayment of debt. Upon completion of the transaction, PharMerica will become a private company. Under the terms of the agreement, PharMerica shareholders will receive $29.25 in cash for each share of PharMerica common stock upon closing of the proposed transaction. The price represents a premium of approximately 17 percent to PharMerica's closing share price as of the last trading day prior to announcement and a premium of approximately 18 percent to PharMerica's 90-day volume weighted average price. The acquisition agreement was unanimously approved by the Board of Directors of PharMerica. KKR is making the investment primarily through its Americas XII Fund. Walgreens Boots Alliance intends to account for its minority ownership interest in PharMerica as an equity method investment. The transaction is subject to PharMerica shareholder approval, regulatory approvals, and other customary closing conditions. PharMerica expects to complete the transaction by early 2018. UBS Investment Bank and BofA Merrill Lynch are serving as financial advisors to PharMerica and Davis Polk & Wardwell LLP is serving as PharMerica's legal advisor. Simpson Thacher & Bartlett LLP and Weil, Gotshal & Manges LLP are serving as legal advisors to KKR and Walgreens Boots Alliance, respectively. Fully committed debt financing will be provided by Goldman Sachs, Morgan Stanley, Wells Fargo, Jefferies and KKR Capital Markets. In light of the agreement with KKR and Walgreens, PharMerica has cancelled its second quarter 2017 earnings conference call previously scheduled to be held on Friday, August 4, 2017, at 10:00 a.m. EDT. PharMerica does not intend to hold earnings conference calls during the pendency of the transaction.

06:58 EDT Southern Company reports Q2 estimated loss on Kemper IGCC of $3.0B - Southern Company said: "Earnings for the three months ended June 30, 2017 and 2016 include the estimated losses relating to Mississippi Power Company's integrated coal gasification combined cycle facility construction project in Kemper County, Mississippi, or the 'Kemper IGCC,' which significantly impacted the presentation of earnings and earnings per share. Further charges of uncertain amounts may occur in future periods in connection with the resolution of the Mississippi Public Service Commission's Kemper Settlement Docket."

06:56 EDT Gas Natural merger with BlackRock Real Assets receives final approval - Gas Natural has received the final regulatory approval required to complete the acquisition of its common stock for $13.10 by a fund managed by BlackRock Real Assets' Global Energy & Power Infrastructure group. The proposed transaction was initially announced in October 2016 by First Reserve Energy Infrastructure Funds, which BlackRock Real Assets acquired in June 2017, and is now expected to close on August 4. The company plans to announce the closing of the transaction when completed.

06:53 EDT BWXT Nuclear Energy Canada awarded C$34M contract - BWX Technologies announced that its subsidiary BWXT Nuclear Energy Canada has been awarded a C$34M, five year contract to supply seven primary heat transport motors for Bruce Power. The motors are part of Bruce Power's life-extension program that will extend the life of six of its reactors to continue providing Ontario with clean, low-cost and reliable electricity for decades to come. The primary heat transport motors are required to drive the main circulating pumps used to push heavy water through the reactor core into the steam generators. The scope of the contract includes the project management, engineering and manufacturing of seven 11,000 horsepower motors. Work under this contract will commence immediately with the first motor scheduled to be delivered to Bruce Power in mid-2018.

06:41 EDT Littelfuse increases div idend 12% to 37c per share - Littelfuse approved a 12% increase in the quarterly cash dividend from 33c to 37c. This equates to an annualized dividend of $1.48 per share. The dividend will be paid on September 7, 2017 to shareholders of record as of August 24, 2017.

06:27 EDT Devon Energy says 'firmly on track' to achieve FY17 production targets - Based on the strong results YTD, Devon said it is "firmly on track" to achieve its FY17 production targets and expects U.S. oil production growth to exit 2017 at a rate of 18%-23% higher than year-end 2016. This growth will be driven by the company's STACK and Delaware Basin assets. Combined, these two franchise assets are expected to increase production by greater than30% by the end of 2017. Due to operational efficiencies, E&P capital spending has been 17% below midpoint guidance in 1H17 or 39% of the 2017 budget. The company has ~55% of its oil and gas production protected for the remainder of 2017, ~25% of its oil and gas production locked-in at favorable prices in Q1 2018 and Devon is actively accumulating additional hedges over the next 18 months. Devon's divestitures will include ~35,000 Boe per day of production from select non-core leasehold within the Barnett Shale and the Eagle Ford, along with other minor properties across the U.S. Comments from slides that will be presented on the Q2 earnings conference call.

06:18 EDT Summit Materials raises FY17 adjusted EBITDA view to $440M-$455M

06:14 EDT Clean Energy awarded multi-year Extension by DART - Clean Energy announced that Dallas Area Rapid Transit has extended Clean Energy's operation and maintenance contract for an additional four years. Clean Energy services DART's four compressed natural gas facilities supporting 537 buses and 123 shuttles and paratransit vehicles. These stations are anticipated to dispense approximately 40M gasoline gallon equivalents over the contract period.

06:08 EDT Jacobs Engineering sees $150M of annual cost savings from CH2M acquisition - Jacobs expects to achieve $150M of annual run-rate cost savings by the end of the second year following the close of the transaction. Savings are expected to come from real estate, optimization of corporate operations, alignment of organizational structures, procurement and IT systems. Jacobs expects to incur approximately $225M in one-time costs to achieve these savings. The transaction value represents an attractive enterprise value multiple of 6.9x TTM adjusted EBITDA3, including cost synergies. Excluding the synergy benefits, the transaction enterprise value represents a multiple of 10.1x TTM adjusted EBITDA. TTM adjusted EBITDA through June 2017 for CH2M is $323M. The transaction is expected to be 25% accretive to Jacobs' adjusted cash earnings per share and 15% accretive to Jacobs' adjusted earnings per share in the first full year post-close.Following the close of the transaction, Jacobs expects to maintain an investment grade credit profile with net debt-to-TTM adjusted EBITDA of 1.9x. Post-close, 85% of Jacobs' combined revenue is expected to be derived from projects with reimbursable or lower risk services - continuing to be one of the best risk profiles in the industry.

06:05 EDT OpenSignal: Unlimited data plans slowing down mobile speeds for Verizon, AT&T - Unlimited data plans are slowing down mobile speeds for Verizon (VZ) and AT&T (T) customers, according to data released by mobile network measurement company OpenSignal. According to OpenSignal, "Six months after reintroducing unlimited plans, Verizon and AT&T experienced a marked decline in 4G speeds in our tests. The impact appears to have hit Verizon the most. Its average LTE download test fell 2 Mbps to 14.9 Mbps in the six months between reports." Additionally, T-Mobile (TMUS) edged out Verizon in our 4G availability metric, but it was a very close call. Our testers were able to find a 4G signal on T-Mobile 90.9% of the time compared to 89.8% of the time on Verizon. As both T-Mobile and Sprint (S) have offered unlimited data plans for some time, OpenSignal didn't see any adverse effect on their speeds. In fact, both operators' LTE speeds climbed upwards in the last six months. T-Mobile was the fastest operator in our test results with average LTE download speeds of 17.5 Mbps and overall speeds of 16.1 Mbps. T-Mobile may have had the upper hand in our nationwide metrics, but in our city analysis, Verizon and T-Mobile were in a heated battle for dominance. One of the two operators either won outright or tied for our 4G speed and availability awards in all of the 32 markets we examined." Reference Link

06:02 EDT YouTube details additional steps to fight terror content online - YouTube has detailed additional steps to fight terrorist content, including machine learning-based detection and consultation with wider panel of experts. In a blog post, YouTube says, "We recently began developing and implementing cutting-edge machine learning technology designed to help us identify and remove violent extremism and terrorism-related content in a scalable way. We have started rolling out these tools and we are already seeing some positive progress. Of course, our systems are only as good as the the data they're based on. Over the past weeks, we have begun working with more than 15 additional expert NGOs and institutions through our Trusted Flagger program, including the Anti-Defamation League, the No Hate Speech Movement, and the Institute for Strategic Dialogue. These organizations bring expert knowledge of complex issues like hate speech, radicalization, and terrorism that will help us better identify content that is being used to radicalize and recruit extremists. We will also regularly consult these experts as we update our policies to reflect new trends. And we'll continue to add more organizations to our network of advisors over time. We'll soon be applying tougher treatment to videos that aren't illegal but have been flagged by users as potential violations of our policies on hate speech and violent extremism. If we find that these videos don't violate our policies but contain controversial religious or supremacist content, they will be placed in a limited state. The videos will remain on YouTube behind an interstitial, won't be recommended, won't be monetized, and won't have key features including comments, suggested videos, and likes. We'll begin to roll this new treatment out to videos on desktop versions of YouTube in the coming weeks, and will bring it to mobile experiences soon thereafter. We've started rolling out features from Jigsaw's Redirect Method to YouTube. When people search for sensitive keywords on YouTube, they will be redirected towards a playlist of curated YouTube videos that directly confront and debunk violent extremist messages. We also continue to amplify YouTube voices speaking out against hate and radicalization through our YouTube Creators for Change program... Altogether, we have taken significant steps over the last month in our fight against online terrorism. But this is not the end. We know there is always more work to be done."

06:00 EDT Google Classroom passes 1B submitted assignments, gets 10 new features - Sarah Wu, a software engineer for Google Classroom, says in a blog post, "Classroom is a useful tool for teachers, and since it launched three years ago, students have submitted more than 1 billion assignments. This year, we're sending teachers back to school with updates designed to help them do what they do best-teach. Today, we're announcing 10 updates to Google Classroom and Google Forms to help teachers save time and stay organized." Updates include: Single view of student work, reorder classes, transfer class ownership and decimal grading. Reference Link

05:49 EDT CTI BioPharma completes enrollment in PIX306 Phase 3 trial of Pixuvri - CTI BioPharma announced the completion of enrollment in the Phase 3 PIX306 trial of Pixuvri. The PIX306 trial is evaluating Pixuvri combined with rituximab in comparison to that of rituximab combined with gemcitabine in patients with aggressive B-cell non-Hodgkin lymphoma, or NHL. Patients eligible to be enrolled in the trial had failed front line CHOP-R and were not eligible for autologous stem cell transplant or failed ASCT. PIXUVRI has previously been granted conditional marketing authorization from the European Commission for the treatment of adult patients with multiply relapsed or refractory aggressive B-cell NHL.i The trial is being conducted as a post-authorization requirement of conditional marketing authorization. If positive, the results from this trial could support broader indications. Top-line results are event-driven and are expected in the first half of 2018.

05:41 EDT Great Panther Silver appoints Jim Bannantine as CEO - Great Panther Silver announces the appointment of Jim Bannantine as president and CEO, effective August 16. Bannantine will succeed Robert Archer, who, in April 2017, announced his intention to step down this year. Archer is a co-founder of the company and will remain on the Board of Directors. Most recently, Jim was president and CEO of Aura Minerals.

05:35 EDT Teck Resources provides update regarding Waneta Dam sale - Teck Resources (TECK) announced that BC Hydro has exercised its right of first offer to purchase Teck's two-thirds interest in the Waneta Dam in British Columbia, Canada, for C$1.2B cash. There are no material changes to the commercial terms of the previously announced Waneta purchase agreement between Fortis (FTS), and Teck. Under the agreement, Teck Metals will be granted a 20-year lease to use the two-thirds interest in Waneta to produce power for its industrial operations in Trail. Annual payments will begin at approximately $75M per year and escalate at 2% per annum, equivalent to an initial power price of C$40/MWh based on 1,880 GWh of energy per annum. Teck Metals will have an option to extend the lease for a further 10 years at comparable rates. Under the Waneta purchase agreement with Fortis, Teck expects to pay Fortis a break fee of approximately C$28M. Teck expects to realize a net book gain of approximately C$800M on closing. No cash tax will be payable on the proceeds. Closing of the transaction is subject to customary conditions, including receipt of regulatory approvals and certain consents, and is not expected before Q1 of 2018.

05:31 EDT Kayne Anderson Energy reports net assets $197M at July 31 - Kayne Anderson Energy provided a summary unaudited statement of assets and liabilities and announced its net asset value and asset coverage ratios under the Investment Company Act of 1940 as of July 31. As of July 31, 2017, the Company's net assets were $197M, and its net asset value per share was $18.31. As of July 31, 2017, the company's asset coverage ratio under the 1940 Act with respect to senior securities representing indebtedness was 417% and the company's asset coverage ratio under the 1940 Act with respect to total leverage was 307%.

05:27 EDT Kayne Anderson MLP MLP reports net assets $2.1B at July 31 - Kayne Anderson MLP provided a summary unaudited statement of assets and liabilities and announced its net asset value and asset coverage ratios under the Investment Company Act of 1940 as of July 31. As of July 31, 2017, the company's net assets were $2.1B, and its net asset value per share was $18.27. As of July 31, 2017, the company's asset coverage ratio under the 1940 Act with respect to senior securities representing indebtedness was 407% and the company's asset coverage ratio under the 1940 Act with respect to total leverage was 296%.